Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Women with Polycystic Ovary Syndrome have higher levels of the hormone ghrelin, which may be linked to the cause of the condition.

A woman with anorexia and Cushing's syndrome improved after tumor removal, highlighting the need to consider hormonal issues in psychiatric conditions.

Early signs of PCOS in girls, like irregular periods and polycystic ovaries, suggest a need for early diagnosis and intervention to prevent further health issues.

Diagnosing hyperandrogenism in women is complex and requires accurate testing methods and consideration of SHBG levels.

Higher doses of oestradiol implants improve bone density in postmenopausal women.

Men with low or no sperm count have lower salivary testosterone levels, and saliva testing can measure their testosterone well.

The document concludes that individualized Facial Feminization Surgery plans and comprehensive care are crucial for successful outcomes.

A young woman with kidney failure had hair loss due to a common hormonal disorder, which improved with hormone therapy.

People often struggle to consistently use contraceptives and other medications, and long-acting options might be better for those who want to avoid daily doses.

Sertraline can cause hair loss, which stops after stopping the drug.

Sex hormones, especially androgens, play a key role in causing acne.

Deslorelin implants successfully treated hair loss in two male Keeshonden dogs.

Finasteride, when taken daily, lowers dihydrotestosterone levels but doesn't noticeably affect adrenal steroid production, except by blocking the 5 alpha-reductase enzyme.

Early-onset male baldness may increase the risk of metabolic syndrome.

Fadrozole and finasteride change gene expression related to sex hormones and thyroid hormones in frog larvae development.

Irregular menstrual cycles in exercising women may be linked to energy deficiency or hormonal imbalances, requiring careful diagnosis for proper treatment.

Spironolactone may help reduce excessive hair growth in women with high male hormone levels.

High levels of cortisol in hair show long-term stress which can lower fertility in animals.

Accurate diagnosis and timely, tailored treatments improve outcomes in obstetrics and gynecology.

New treatments for hair loss, fertility, and wound healing are being explored.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

Cabergoline is more effective and has fewer side effects than bromocriptine for treating women with hyperprolactinemic amenorrhea.

Diazoxide applied to the skin can increase hair growth without harmful side effects.

Surgical and chemical castration have varied effects on heart and brain inflammation and artery function in sick rats.

A 14-year-old girl with no menstrual period was diagnosed with Swyer Syndrome and treated for a related cancer risk.

Methylphenidate can cause hair loss, which stops when the drug is discontinued.

The spiny mouse is a unique menstruating rodent that can help us understand menstruation and reproductive disorders.